STRYKER CORP false 0000310764 0000310764 2026-05-15 2026-05-15 0000310764 us-gaap:CommonStockMember 2026-05-15 2026-05-15 0000310764 syk:M2.125NotesDue20272Member 2026-05-15 2026-05-15 0000310764 syk:SeniorUnsecuredNotes0.250Due2024Member 2026-05-15 2026-05-15 0000310764 syk:M0.750NotesDue20291Member 2026-05-15 2026-05-15 0000310764 syk:SeniorUnsecuredNotes3.375Due2028Member 2026-05-15 2026-05-15 0000310764 syk:SeniorUnsecuredNotes0.750Due2029Member 2026-05-15 2026-05-15 0000310764 syk:SeniorUnsecuredNotes2.625Due2030Member 2026-05-15 2026-05-15 0000310764 syk:SeniorUnsecuredNotes1.000Due2031Member 2026-05-15 2026-05-15

false0000310764P3YP3YP4Y33.33http://fasb.org/us-gaap/2025#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2025#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2025#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2025#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2025#AccountsPayableTradeCurrenthttp://fasb.org/us-gaap/2025#AssetImpairmentChargeshttp://fasb.org/us-gaap/2025#AssetImpairmentChargeshttp://fasb.org/us-gaap/2025#AssetImpairmentChargeshttp://fasb.org/us-gaap/2025#AssetImpairmentChargesiso4217:USDiso4217:USDxbrli:sharesxbrli:sharessyk:segmentxbrli:pureiso4217:EURsyk:class_of_stock00003107642026-06-262026-06-260000310764us-gaap:CommonStockMember2026-06-262026-06-260000310764syk:SeniorUnsecuredNotes2.125Due2027Member2026-06-262026-06-260000310764syk:SeniorUnsecuredNotes3375Due2028Member2026-06-262026-06-260000310764syk:SeniorUnsecuredNotes0.750Due2029Member2026-06-262026-06-260000310764syk:SeniorUnsecuredNotes2.625Due2030Member2026-06-262026-06-260000310764syk:SeniorUnsecuredNotes1.000Due2031Member2026-06-262026-06-260000310764syk:SeniorUnsecuredNotes3.375Due2032Member2026-06-262026-06-260000310764syk:SeniorUnsecuredNotes3.625Due2036Member2026-06-262026-06-2600003107642025-01-012025-12-3100003107642024-01-012024-12-3100003107642023-01-012023-12-3100003107642025-12-3100003107642024-12-310000310764us-gaap:CommonStockMember2024-12-310000310764us-gaap:CommonStockMember2023-12-310000310764us-gaap:CommonStockMember2022-12-310000310764us-gaap:CommonStockMember2025-01-012025-12-310000310764us-gaap:CommonStockMember2024-01-012024-12-310000310764us-gaap:CommonStockMember2023-01-012023-12-310000310764us-gaap:CommonStockMember2025-12-310000310764us-gaap:AdditionalPaidInCapitalMember2024-12-310000310764us-gaap:AdditionalPaidInCapitalMember2023-12-310000310764us-gaap:AdditionalPaidInCapitalMember2022-12-310000310764us-gaap:AdditionalPaidInCapitalMember2025-01-012025-12-310000310764us-gaap:AdditionalPaidInCapitalMember2024-01-012024-12-310000310764us-gaap:AdditionalPaidInCapitalMember2023-01-012023-12-310000310764us-gaap:AdditionalPaidInCapitalMember2025-12-310000310764us-gaap:RetainedEarningsMember2024-12-310000310764us-gaap:RetainedEarningsMember2023-12-310000310764us-gaap:RetainedEarningsMember2022-12-310000310764us-gaap:RetainedEarningsMember2025-01-012025-12-310000310764us-gaap:RetainedEarningsMember2024-01-012024-12-310000310764us-gaap:RetainedEarningsMember2023-01-012023-12-310000310764us-gaap:RetainedEarningsMember2025-12-310000310764us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310000310764us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310000310764us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000310764us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-12-310000310764us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-12-310000310764us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-3100003107642023-12-3100003107642022-12-3100003107642026-01-012026-03-310000310764srt:MinimumMemberus-gaap:BuildingAndBuildingImprovementsMember2025-12-310000310764srt:MaximumMemberus-gaap:BuildingAndBuildingImprovementsMember2025-12-310000310764srt:MinimumMemberus-gaap:MachineryAndEquipmentMember2025-12-310000310764srt:MaximumMemberus-gaap:MachineryAndEquipmentMember2025-12-310000310764srt:MinimumMember2025-12-310000310764srt:MaximumMember2025-12-310000310764us-gaap:EmployeeStockOptionMember2025-01-012025-12-310000310764us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-12-310000310764syk:PerformanceStockUnitPsusMember2025-01-012025-12-310000310764syk:OrthopaedicInstrumentsMember2025-01-012025-12-310000310764syk:OrthopaedicInstrumentsMember2024-01-012024-12-310000310764syk:OrthopaedicInstrumentsMember2023-01-012023-12-310000310764syk:OtherOrthopedicsMember2025-01-012025-12-310000310764syk:OtherOrthopedicsMember2024-01-012024-12-310000310764syk:OtherOrthopedicsMember2023-01-012023-12-310000310764syk:EnablingTechnologiesMember2025-01-012025-12-310000310764syk:EnablingTechnologiesMember2024-01-012024-12-310000310764syk:EnablingTechnologiesMember2023-01-012023-12-310000310764syk:InstrumentsMembersyk:MedSurgAndNeurotechnologyMember2025-01-012025-12-310000310764syk:InstrumentsMembersyk:MedSurgAndNeurotechnologyMember2024-01-012024-12-310000310764syk:InstrumentsMembersyk:MedSurgAndNeurotechnologyMember2023-01-012023-12-310000310764syk:EndoscopyMembersyk:MedSurgAndNeurotechnologyMember2025-01-012025-12-310000310764syk:EndoscopyMembersyk:MedSurgAndNeurotechnologyMember2024-01-012024-12-310000310764syk:EndoscopyMembersyk:MedSurgAndNeurotechnologyMember2023-01-012023-12-310000310764syk:MedicalMembersyk:MedSurgAndNeurotechnologyMember2025-01-012025-12-310000310764syk:MedicalMembersyk:MedSurgAndNeurotechnologyMember2024-01-012024-12-310000310764syk:MedicalMembersyk:MedSurgAndNeurotechnologyMember2023-01-012023-12-310000310764syk:NeurovascularMembersyk:MedSurgAndNeurotechnologyMember2025-01-012025-12-310000310764syk:NeurovascularMembersyk:MedSurgAndNeurotechnologyMember2024-01-012024-12-310000310764syk:NeurovascularMembersyk:MedSurgAndNeurotechnologyMember2023-01-012023-12-310000310764syk:NeuroCranialMembersyk:MedSurgAndNeurotechnologyMember2025-01-012025-12-310000310764syk:NeuroCranialMembersyk:MedSurgAndNeurotechnologyMember2024-01-012024-12-310000310764syk:NeuroCranialMembersyk:MedSurgAndNeurotechnologyMember2023-01-012023-12-310000310764syk:MedSurgAndNeurotechnologyMember2025-01-012025-12-310000310764syk:MedSurgAndNeurotechnologyMember2024-01-012024-12-310000310764syk:MedSurgAndNeurotechnologyMember2023-01-012023-12-310000310764syk:KneesMembersyk:OrthopaedicsMember2025-01-012025-12-310000310764syk:KneesMembersyk:OrthopaedicsMember2024-01-012024-12-310000310764syk:KneesMembersyk:OrthopaedicsMember2023-01-012023-12-310000310764syk:HipsMembersyk:OrthopaedicsMember2025-01-012025-12-310000310764syk:HipsMembersyk:OrthopaedicsMember2024-01-012024-12-310000310764syk:HipsMembersyk:OrthopaedicsMember2023-01-012023-12-310000310764syk:TraumaandExtremitiesMembersyk:OrthopaedicsMember2025-01-012025-12-310000310764syk:TraumaandExtremitiesMembersyk:OrthopaedicsMember2024-01-012024-12-310000310764syk:TraumaandExtremitiesMembersyk:OrthopaedicsMember2023-01-012023-12-310000310764syk:OrthoTechMembersyk:OrthopaedicsMember2025-01-012025-12-310000310764syk:OrthoTechMembersyk:OrthopaedicsMember2024-01-012024-12-310000310764syk:OrthoTechMembersyk:OrthopaedicsMember2023-01-012023-12-310000310764syk:SpinalImplantsMembersyk:OrthopaedicsMember2025-01-012025-12-310000310764syk:SpinalImplantsMembersyk:OrthopaedicsMember2024-01-012024-12-310000310764syk:SpinalImplantsMembersyk:OrthopaedicsMember2023-01-012023-12-310000310764syk:OrthopaedicsMember2025-01-012025-12-310000310764syk:OrthopaedicsMember2024-01-012024-12-310000310764syk:OrthopaedicsMember2023-01-012023-12-310000310764syk:InstrumentsMembercountry:USsyk:MedSurgAndNeurotechnologyMember2025-01-012025-12-310000310764syk:InstrumentsMembercountry:USsyk:MedSurgAndNeurotechnologyMember2024-01-012024-12-310000310764syk:InstrumentsMembercountry:USsyk:MedSurgAndNeurotechnologyMember2023-01-012023-12-310000310764syk:EndoscopyMembercountry:USsyk:MedSurgAndNeurotechnologyMember2025-01-012025-12-310000310764syk:EndoscopyMembercountry:USsyk:MedSurgAndNeurotechnologyMember2024-01-012024-12-310000310764syk:EndoscopyMembercountry:USsyk:MedSurgAndNeurotechnologyMember2023-01-012023-12-310000310764syk:MedicalMembercountry:USsyk:MedSurgAndNeurotechnologyMember2025-01-012025-12-310000310764syk:MedicalMembercountry:USsyk:MedSurgAndNeurotechnologyMember2024-01-012024-12-310000310764syk:MedicalMembercountry:USsyk:MedSurgAndNeurotechnologyMember2023-01-012023-12-310000310764syk:NeurovascularMembercountry:USsyk:MedSurgAndNeurotechnologyMember2025-01-012025-12-310000310764syk:NeurovascularMembercountry:USsyk:MedSurgAndNeurotechnologyMember2024-01-012024-12-310000310764syk:NeurovascularMembercountry:USsyk:MedSurgAndNeurotechnologyMember2023-01-012023-12-310000310764syk:NeuroCranialMembercountry:USsyk:MedSurgAndNeurotechnologyMember2025-01-012025-12-310000310764syk:NeuroCranialMembercountry:USsyk:MedSurgAndNeurotechnologyMember2024-01-012024-12-310000310764syk:NeuroCranialMembercountry:USsyk:MedSurgAndNeurotechnologyMember2023-01-012023-12-310000310764country:USsyk:MedSurgAndNeurotechnologyMember2025-01-012025-12-310000310764country:USsyk:MedSurgAndNeurotechnologyMember2024-01-012024-12-310000310764country:USsyk:MedSurgAndNeurotechnologyMember2023-01-012023-12-310000310764syk:KneesMembercountry:USsyk:OrthopaedicsMember2025-01-012025-12-310000310764syk:KneesMembercountry:USsyk:OrthopaedicsMember2024-01-012024-12-310000310764syk:KneesMembercountry:USsyk:OrthopaedicsMember2023-01-012023-12-310000310764syk:HipsMembercountry:USsyk:OrthopaedicsMember2025-01-012025-12-310000310764syk:HipsMembercountry:USsyk:OrthopaedicsMember2024-01-012024-12-310000310764syk:HipsMembercountry:USsyk:OrthopaedicsMember2023-01-012023-12-310000310764syk:TraumaandExtremitiesMembercountry:USsyk:OrthopaedicsMember2025-01-012025-12-310000310764syk:TraumaandExtremitiesMembercountry:USsyk:OrthopaedicsMember2024-01-012024-12-310000310764syk:TraumaandExtremitiesMembercountry:USsyk:OrthopaedicsMember2023-01-012023-12-310000310764syk:OrthoTechMembercountry:USsyk:OrthopaedicsMember2025-01-012025-12-310000310764syk:OrthoTechMembercountry:USsyk:OrthopaedicsMember2024-01-012024-12-310000310764syk:OrthoTechMembercountry:USsyk:OrthopaedicsMember2023-01-012023-12-310000310764syk:SpinalImplantsMembercountry:USsyk:OrthopaedicsMember2025-01-012025-12-310000310764syk:SpinalImplantsMembercountry:USsyk:OrthopaedicsMember2024-01-012024-12-310000310764syk:SpinalImplantsMembercountry:USsyk:OrthopaedicsMember2023-01-012023-12-310000310764country:USsyk:OrthopaedicsMember2025-01-012025-12-310000310764country:USsyk:OrthopaedicsMember2024-01-012024-12-310000310764country:USsyk:OrthopaedicsMember2023-01-012023-12-310000310764country:US2025-01-012025-12-310000310764country:US2024-01-012024-12-310000310764country:US2023-01-012023-12-310000310764syk:InstrumentsMemberus-gaap:NonUsMembersyk:MedSurgAndNeurotechnologyMember2025-01-012025-12-310000310764syk:InstrumentsMemberus-gaap:NonUsMembersyk:MedSurgAndNeurotechnologyMember2024-01-012024-12-310000310764syk:InstrumentsMemberus-gaap:NonUsMembersyk:MedSurgAndNeurotechnologyMember2023-01-012023-12-310000310764syk:EndoscopyMemberus-gaap:NonUsMembersyk:MedSurgAndNeurotechnologyMember2025-01-012025-12-310000310764syk:EndoscopyMemberus-gaap:NonUsMembersyk:MedSurgAndNeurotechnologyMember2024-01-012024-12-310000310764syk:EndoscopyMemberus-gaap:NonUsMembersyk:MedSurgAndNeurotechnologyMember2023-01-012023-12-310000310764syk:MedicalMemberus-gaap:NonUsMembersyk:MedSurgAndNeurotechnologyMember2025-01-012025-12-310000310764syk:MedicalMemberus-gaap:NonUsMembersyk:MedSurgAndNeurotechnologyMember2024-01-012024-12-310000310764syk:MedicalMemberus-gaap:NonUsMembersyk:MedSurgAndNeurotechnologyMember2023-01-012023-12-310000310764syk:NeurovascularMemberus-gaap:NonUsMembersyk:MedSurgAndNeurotechnologyMember2025-01-012025-12-310000310764syk:NeurovascularMemberus-gaap:NonUsMembersyk:MedSurgAndNeurotechnologyMember2024-01-012024-12-310000310764syk:NeurovascularMemberus-gaap:NonUsMembersyk:MedSurgAndNeurotechnologyMember2023-01-012023-12-310000310764syk:NeuroCranialMemberus-gaap:NonUsMembersyk:MedSurgAndNeurotechnologyMember2025-01-012025-12-310000310764syk:NeuroCranialMemberus-gaap:NonUsMembersyk:MedSurgAndNeurotechnologyMember2024-01-012024-12-310000310764syk:NeuroCranialMemberus-gaap:NonUsMembersyk:MedSurgAndNeurotechnologyMember2023-01-012023-12-310000310764us-gaap:NonUsMembersyk:MedSurgAndNeurotechnologyMember2025-01-012025-12-310000310764us-gaap:NonUsMembersyk:MedSurgAndNeurotechnologyMember2024-01-012024-12-310000310764us-gaap:NonUsMembersyk:MedSurgAndNeurotechnologyMember2023-01-012023-12-310000310764syk:KneesMemberus-gaap:NonUsMembersyk:OrthopaedicsMember2025-01-012025-12-310000310764syk:KneesMemberus-gaap:NonUsMembersyk:OrthopaedicsMember2024-01-012024-12-310000310764syk:KneesMemberus-gaap:NonUsMembersyk:OrthopaedicsMember2023-01-012023-12-310000310764syk:HipsMemberus-gaap:NonUsMembersyk:OrthopaedicsMember2025-01-012025-12-310000310764syk:HipsMemberus-gaap:NonUsMembersyk:OrthopaedicsMember2024-01-012024-12-310000310764syk:HipsMemberus-gaap:NonUsMembersyk:OrthopaedicsMember2023-01-012023-12-310000310764syk:TraumaandExtremitiesMemberus-gaap:NonUsMembersyk:OrthopaedicsMember2025-01-012025-12-310000310764syk:TraumaandExtremitiesMemberus-gaap:NonUsMembersyk:OrthopaedicsMember2024-01-012024-12-310000310764syk:TraumaandExtremitiesMemberus-gaap:NonUsMembersyk:OrthopaedicsMember2023-01-012023-12-310000310764syk:OrthoTechMemberus-gaap:NonUsMembersyk:OrthopaedicsMember2025-01-012025-12-310000310764syk:OrthoTechMemberus-gaap:NonUsMembersyk:OrthopaedicsMember2024-01-012024-12-310000310764syk:OrthoTechMemberus-gaap:NonUsMembersyk:OrthopaedicsMember2023-01-012023-12-310000310764syk:SpinalImplantsMemberus-gaap:NonUsMembersyk:OrthopaedicsMember2025-01-012025-12-310000310764syk:SpinalImplantsMemberus-gaap:NonUsMembersyk:OrthopaedicsMember2024-01-012024-12-310000310764syk:SpinalImplantsMemberus-gaap:NonUsMembersyk:OrthopaedicsMember2023-01-012023-12-310000310764us-gaap:NonUsMembersyk:OrthopaedicsMember2025-01-012025-12-310000310764us-gaap:NonUsMembersyk:OrthopaedicsMember2024-01-012024-12-310000310764us-gaap:NonUsMembersyk:OrthopaedicsMember2023-01-012023-12-310000310764us-gaap:NonUsMember2025-01-012025-12-310000310764us-gaap:NonUsMember2024-01-012024-12-310000310764us-gaap:NonUsMember2023-01-012023-12-310000310764syk:CustomerLeaseAgreementsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-012025-12-310000310764syk:CustomerLeaseAgreementsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-12-310000310764syk:CustomerLeaseAgreementsMemberus-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-12-310000310764syk:CerusMember2025-06-300000310764us-gaap:FairValueInputsLevel1Member2025-12-310000310764us-gaap:FairValueInputsLevel1Member2024-12-310000310764us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Member2025-12-310000310764us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Member2024-12-310000310764us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2025-12-310000310764us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2024-12-310000310764us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueInputsLevel2Member2025-12-310000310764us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueInputsLevel2Member2024-12-310000310764us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel2Member2025-12-310000310764us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel2Member2024-12-310000310764us-gaap:FairValueInputsLevel2Member2025-12-310000310764us-gaap:FairValueInputsLevel2Member2024-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel2Member2025-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel2Member2024-12-310000310764us-gaap:FairValueInputsLevel3Member2024-12-310000310764us-gaap:FairValueInputsLevel3Member2023-12-310000310764us-gaap:FairValueInputsLevel3Member2025-01-012025-12-310000310764us-gaap:FairValueInputsLevel3Member2024-01-012024-12-310000310764us-gaap:FairValueInputsLevel3Member2025-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2025-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2025-12-310000310764us-gaap:ForeignExchangeContractMember2025-12-310000310764us-gaap:ForeignExchangeContractMember2025-01-012025-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2025-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:NondesignatedMember2025-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMember2025-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2025-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:NondesignatedMember2025-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentAssetsMember2025-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2025-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:NondesignatedMember2025-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentLiabilitiesMember2025-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2025-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2025-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMember2025-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMember2025-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2024-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2024-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-12-310000310764us-gaap:ForeignExchangeContractMember2024-12-310000310764us-gaap:ForeignExchangeContractMember2024-01-012024-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2024-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2024-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:NondesignatedMember2024-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMember2024-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2024-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2024-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:NondesignatedMember2024-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentAssetsMember2024-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2024-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2024-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:NondesignatedMember2024-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentLiabilitiesMember2024-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2024-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMember2024-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMember2024-12-310000310764us-gaap:EmbeddedDerivativeFinancialInstrumentsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2025-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-01-012025-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMember2025-01-012025-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMember2024-01-012024-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMember2023-01-012023-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMembersyk:OtherIncomeexpenseMember2025-01-012025-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMembersyk:OtherIncomeexpenseMember2024-01-012024-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMembersyk:OtherIncomeexpenseMember2023-01-012023-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMembersyk:OtherIncomeexpenseMember2025-01-012025-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMembersyk:OtherIncomeexpenseMember2024-01-012024-12-310000310764us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMembersyk:OtherIncomeexpenseMember2023-01-012023-12-310000310764us-gaap:ForeignExchangeContractMember2023-01-012023-12-310000310764us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2025-01-012025-12-310000310764us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310000310764us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-12-310000310764us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310000310764us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2023-12-310000310764us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-12-310000310764us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-01-012024-12-310000310764us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-12-310000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-12-310000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-01-012024-12-310000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-12-310000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-12-310000310764us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-12-310000310764us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-12-310000310764us-gaap:AccumulatedTranslationAdjustmentMember2024-12-310000310764us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2024-12-310000310764us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-01-012025-12-310000310764us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-01-012025-12-310000310764us-gaap:AccumulatedTranslationAdjustmentMember2025-01-012025-12-310000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-01-012025-12-310000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-01-012025-12-310000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedTranslationAdjustmentMember2025-01-012025-12-310000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2025-01-012025-12-310000310764us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2025-12-310000310764us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-12-310000310764us-gaap:AccumulatedTranslationAdjustmentMember2025-12-310000310764us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2025-12-310000310764syk:InariMember2025-02-280000310764syk:InariMember2025-02-012025-02-280000310764syk:InariMember2025-01-012025-12-310000310764syk:VariousMember2024-01-012024-12-310000310764syk:VariousMember2024-12-310000310764syk:InariMedicalInc.MergerMember2025-12-310000310764syk:InariMedicalInc.MergerMemberus-gaap:DevelopedTechnologyRightsMember2025-12-310000310764syk:VariousMemberus-gaap:DevelopedTechnologyRightsMember2024-12-310000310764syk:InariMedicalInc.MergerMemberus-gaap:CustomerRelationshipsMember2025-12-310000310764syk:VariousMemberus-gaap:CustomerRelationshipsMember2024-12-310000310764syk:InariMedicalInc.MergerMemberus-gaap:PatentsMember2025-12-310000310764syk:VariousMemberus-gaap:PatentsMember2024-12-310000310764syk:InariMedicalInc.MergerMemberus-gaap:TrademarksMember2025-12-310000310764syk:VariousMemberus-gaap:TrademarksMember2024-12-310000310764syk:InariMedicalInc.MergerMemberus-gaap:OtherIntangibleAssetsMember2025-12-310000310764syk:VariousMemberus-gaap:OtherIntangibleAssetsMember2024-12-310000310764syk:InariMedicalInc.MergerMember2025-01-012025-12-310000310764syk:VariousMember2023-05-022023-05-020000310764syk:InariMedicalInc.MergerMemberus-gaap:DevelopedTechnologyRightsMember2025-01-012025-12-310000310764syk:VariousMemberus-gaap:DevelopedTechnologyRightsMember2024-01-012024-12-310000310764syk:InariMedicalInc.MergerMemberus-gaap:CustomerRelationshipsMember2025-01-012025-12-310000310764syk:VariousMemberus-gaap:CustomerRelationshipsMember2024-01-012024-12-310000310764syk:VariousMemberus-gaap:PatentsMember2024-01-012024-12-310000310764syk:VariousMemberus-gaap:TrademarksMember2024-01-012024-12-310000310764syk:InariMedicalInc.MergerMemberus-gaap:OtherIntangibleAssetsMember2025-01-012025-12-310000310764syk:RecallMattersMember2025-12-310000310764syk:SpineReportingUnitMember2025-01-012025-12-310000310764us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMembersyk:SpinalImplantsMember2025-01-012025-12-3100003107642025-10-310000310764syk:PeripheralVascularReportingUnitMember2025-12-310000310764syk:OrthopaedicsMember2024-01-012024-12-310000310764syk:MedSurgAndNeurotechnologyMember2024-01-012024-12-310000310764syk:MedSurgAndNeurotechnologyMember2023-12-310000310764syk:OrthopaedicsMember2023-12-310000310764syk:MedSurgAndNeurotechnologyMember2024-12-310000310764syk:OrthopaedicsMember2024-12-310000310764syk:MedSurgAndNeurotechnologyMember2025-12-310000310764syk:OrthopaedicsMember2025-12-310000310764us-gaap:DevelopedTechnologyRightsMember2025-12-310000310764us-gaap:DevelopedTechnologyRightsMember2024-12-310000310764us-gaap:CustomerRelationshipsMember2025-12-310000310764us-gaap:CustomerRelationshipsMember2024-12-310000310764us-gaap:PatentsMember2025-12-310000310764us-gaap:PatentsMember2024-12-310000310764us-gaap:TrademarksMember2025-12-310000310764us-gaap:TrademarksMember2024-12-310000310764us-gaap:InProcessResearchAndDevelopmentMember2025-12-310000310764us-gaap:InProcessResearchAndDevelopmentMember2024-12-310000310764us-gaap:OtherIntangibleAssetsMember2025-12-310000310764us-gaap:OtherIntangibleAssetsMember2024-12-310000310764us-gaap:RestrictedStockUnitsRSUMember2024-12-310000310764syk:PerformanceStockUnitPsusMember2024-12-310000310764us-gaap:RestrictedStockUnitsRSUMember2025-12-310000310764syk:PerformanceStockUnitPsusMember2025-12-310000310764us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-12-310000310764us-gaap:EmployeeStockMember2025-01-012025-12-310000310764us-gaap:EmployeeStockMember2024-01-012024-12-310000310764us-gaap:RevolvingCreditFacilityMember2025-02-012025-02-280000310764us-gaap:RevolvingCreditFacilityMember2025-02-280000310764us-gaap:RevolvingCreditFacilityMember2025-12-310000310764us-gaap:CommercialPaperMember2025-02-012025-02-280000310764us-gaap:CommercialPaperMember2025-02-280000310764syk:SeniorUnsecuredNotes4.550Due2027Memberus-gaap:SeniorNotesMember2025-02-280000310764syk:SeniorUnsecuredNotes4.700Due2027Memberus-gaap:SeniorNotesMember2025-02-280000310764syk:SeniorUnsecuredNotes4.850Due2028Memberus-gaap:SeniorNotesMember2025-02-280000310764syk:SeniorUnsecuredNotes5.200Due2035Memberus-gaap:SeniorNotesMember2025-02-280000310764syk:SeniorUnsecuredNotes1.150Due2025Memberus-gaap:SeniorNotesMember2025-06-012025-06-300000310764syk:SeniorUnsecuredNotes1.150Due2025Memberus-gaap:SeniorNotesMember2025-12-310000310764syk:SeniorUnsecuredNotes3.375Due2025Member2025-11-012025-11-300000310764syk:SeniorUnsecuredNotes3.375Due2025Member2025-11-300000310764syk:SeniorUnsecuredNotes1.150Due2025Member2024-12-310000310764syk:SeniorUnsecuredNotes1.150Due2025Member2025-12-310000310764syk:SeniorUnsecuredNotes3.375Due2025Member2024-12-310000310764syk:SeniorUnsecuredNotes3.375Due2025Member2025-12-310000310764syk:SeniorUnsecuredNotes3.500Due2026Member2025-12-310000310764syk:SeniorUnsecuredNotes3.500Due2026Member2024-12-310000310764syk:SeniorUnsecuredNotes4.550Due2027Member2025-12-310000310764syk:SeniorUnsecuredNotes4.550Due2027Member2024-12-310000310764syk:SeniorUnsecuredNotes2.125DueNovember2027Member2025-12-310000310764syk:SeniorUnsecuredNotes2.125DueNovember2027Member2024-12-310000310764syk:SeniorUnsecuredNotes4.700Due2027Member2025-12-310000310764syk:SeniorUnsecuredNotes4.700Due2027Member2024-12-310000310764syk:SeniorUnsecuredNotes3.650Due2028Member2025-12-310000310764syk:SeniorUnsecuredNotes3.650Due2028Member2024-12-310000310764syk:SeniorUnsecuredNotes4.850Due2028Member2025-12-310000310764syk:SeniorUnsecuredNotes4.850Due2028Member2024-12-310000310764syk:SeniorUnsecuredNotes3375Due2028Member2025-12-310000310764syk:SeniorUnsecuredNotes3375Due2028Member2024-12-310000310764syk:SeniorUnsecuredNotes0.750due2029Member2025-12-310000310764syk:SeniorUnsecuredNotes0.750due2029Member2024-12-310000310764syk:SeniorUnsecuredNotes4.250Due2029Member2025-12-310000310764syk:SeniorUnsecuredNotes4.250Due2029Member2024-12-310000310764syk:SeniorUnsecuredNotes4.850Due2030Member2025-12-310000310764syk:SeniorUnsecuredNotes4.850Due2030Member2024-12-310000310764syk:SeniorUnsecuredNotes1.950Due2030Member2025-12-310000310764syk:SeniorUnsecuredNotes1.950Due2030Member2024-12-310000310764syk:SeniorUnsecuredNotes2.625Due2030Member2025-12-310000310764syk:SeniorUnsecuredNotes2.625Due2030Member2024-12-310000310764syk:SeniorUnsecuredNotes1.000due2031Member2025-12-310000310764syk:SeniorUnsecuredNotes1.000due2031Member2024-12-310000310764syk:SeniorUnsecuredNotes3.375Due2032Member2025-12-310000310764syk:SeniorUnsecuredNotes3.375Due2032Member2024-12-310000310764syk:SeniorUnsecuredNotes4.625DueSeptember112034Member2025-12-310000310764syk:SeniorUnsecuredNotes4.625DueSeptember112034Member2024-12-310000310764syk:SeniorUnsecuredNotes5.200Due2035Member2025-12-310000310764syk:SeniorUnsecuredNotes5.200Due2035Member2024-12-310000310764syk:SeniorUnsecuredNotes3.625Due2036Member2025-12-310000310764syk:SeniorUnsecuredNotes3.625Due2036Member2024-12-310000310764syk:SeniorUnsecuredNotes4.100Due2043Member2025-12-310000310764syk:SeniorUnsecuredNotes4.100Due2043Member2024-12-310000310764syk:SeniorUnsecuredNotes4.375due2044Member2025-12-310000310764syk:SeniorUnsecuredNotes4.375due2044Member2024-12-310000310764syk:SeniorUnsecuredNotes4625Due2046Member2025-12-310000310764syk:SeniorUnsecuredNotes4625Due2046Member2024-12-310000310764syk:SeniorUnsecuredNotes2.900due2050Member2025-12-310000310764syk:SeniorUnsecuredNotes2.900due2050Member2024-12-310000310764country:IE2025-01-012025-12-310000310764country:PR2025-01-012025-12-310000310764us-gaap:ForeignTaxJurisdictionOtherMember2025-01-012025-12-310000310764country:US2025-01-012025-12-310000310764us-gaap:DomesticCountryMember2025-12-310000310764us-gaap:StateAndLocalJurisdictionMember2025-12-310000310764us-gaap:ForeignCountryMember2025-12-310000310764country:DE2025-01-012025-12-310000310764srt:ScenarioForecastMembercountry:DE2026-01-012026-12-310000310764us-gaap:OtherNoncurrentAssetsMember2025-12-310000310764us-gaap:OtherNoncurrentAssetsMember2024-12-310000310764syk:AccruedCompensationMember2025-12-310000310764syk:AccruedCompensationMember2024-12-310000310764us-gaap:OtherNoncurrentLiabilitiesMember2025-12-310000310764us-gaap:OtherNoncurrentLiabilitiesMember2024-12-310000310764us-gaap:DefinedBenefitPlanEquitySecuritiesMember2025-12-310000310764us-gaap:DefinedBenefitPlanEquitySecuritiesMember2024-12-310000310764us-gaap:DefinedBenefitPlanDebtSecurityMember2025-12-310000310764us-gaap:DefinedBenefitPlanDebtSecurityMember2024-12-310000310764us-gaap:OtherLongTermInvestmentsMember2025-12-310000310764us-gaap:OtherLongTermInvestmentsMember2024-12-310000310764us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel1Member2025-12-310000310764us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel2Member2025-12-310000310764us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel3Member2025-12-310000310764us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2025-12-310000310764us-gaap:DefinedBenefitPlanEquitySecuritiesMemberus-gaap:FairValueInputsLevel1Member2025-12-310000310764us-gaap:DefinedBenefitPlanEquitySecuritiesMemberus-gaap:FairValueInputsLevel2Member2025-12-310000310764us-gaap:DefinedBenefitPlanEquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2025-12-310000310764us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2025-12-310000310764us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2025-12-310000310764us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2025-12-310000310764us-gaap:CorporateDebtSecuritiesMember2025-12-310000310764us-gaap:OtherDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2025-12-310000310764us-gaap:OtherDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2025-12-310000310764us-gaap:OtherDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2025-12-310000310764us-gaap:OtherDebtSecuritiesMember2025-12-310000310764us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel1Member2024-12-310000310764us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel2Member2024-12-310000310764us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel3Member2024-12-310000310764us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember2024-12-310000310764us-gaap:DefinedBenefitPlanEquitySecuritiesMemberus-gaap:FairValueInputsLevel1Member2024-12-310000310764us-gaap:DefinedBenefitPlanEquitySecuritiesMemberus-gaap:FairValueInputsLevel2Member2024-12-310000310764us-gaap:DefinedBenefitPlanEquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2024-12-310000310764us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2024-12-310000310764us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2024-12-310000310764us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2024-12-310000310764us-gaap:CorporateDebtSecuritiesMember2024-12-310000310764us-gaap:OtherDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2024-12-310000310764us-gaap:OtherDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2024-12-310000310764us-gaap:OtherDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2024-12-310000310764us-gaap:OtherDebtSecuritiesMember2024-12-3100003107642025-01-012025-03-3100003107642025-04-012025-06-3000003107642025-07-012025-09-3000003107642025-10-012025-12-3100003107642024-01-012024-03-3100003107642024-04-012024-06-3000003107642024-07-012024-09-3000003107642024-10-012024-12-310000310764us-gaap:OperatingSegmentsMembersyk:MedSurgAndNeurotechnologyMember2025-01-012025-12-310000310764us-gaap:OperatingSegmentsMembersyk:MedSurgAndNeurotechnologyMember2024-01-012024-12-310000310764us-gaap:OperatingSegmentsMembersyk:MedSurgAndNeurotechnologyMember2023-01-012023-12-310000310764us-gaap:OperatingSegmentsMembersyk:OrthopaedicsMember2025-01-012025-12-310000310764us-gaap:OperatingSegmentsMembersyk:OrthopaedicsMember2024-01-012024-12-310000310764us-gaap:OperatingSegmentsMembersyk:OrthopaedicsMember2023-01-012023-12-310000310764us-gaap:OperatingSegmentsMember2025-01-012025-12-310000310764us-gaap:OperatingSegmentsMember2024-01-012024-12-310000310764us-gaap:OperatingSegmentsMember2023-01-012023-12-310000310764us-gaap:CorporateNonSegmentMember2025-01-012025-12-310000310764us-gaap:CorporateNonSegmentMember2024-01-012024-12-310000310764us-gaap:CorporateNonSegmentMember2023-01-012023-12-310000310764us-gaap:MaterialReconcilingItemsMember2025-01-012025-12-310000310764us-gaap:MaterialReconcilingItemsMember2024-01-012024-12-310000310764us-gaap:MaterialReconcilingItemsMember2023-01-012023-12-310000310764country:US2025-12-310000310764country:US2024-12-310000310764us-gaap:EMEAMember2025-01-012025-12-310000310764us-gaap:EMEAMember2024-01-012024-12-310000310764us-gaap:EMEAMember2023-01-012023-12-310000310764us-gaap:EMEAMember2025-12-310000310764us-gaap:EMEAMember2024-12-310000310764srt:AsiaPacificMember2025-01-012025-12-310000310764srt:AsiaPacificMember2024-01-012024-12-310000310764srt:AsiaPacificMember2023-01-012023-12-310000310764srt:AsiaPacificMember2025-12-310000310764srt:AsiaPacificMember2024-12-310000310764syk:OtherForeignCountriesMember2025-01-012025-12-310000310764syk:OtherForeignCountriesMember2024-01-012024-12-310000310764syk:OtherForeignCountriesMember2023-01-012023-12-310000310764syk:OtherForeignCountriesMember2025-12-310000310764syk:OtherForeignCountriesMember2024-12-310000310764syk:LongLivedAssetsAndIntangibleAssetsMember2025-01-012025-12-310000310764syk:LongLivedAssetsAndIntangibleAssetsMember2024-01-012024-12-310000310764syk:LongLivedAssetsAndIntangibleAssetsMember2023-01-012023-12-310000310764us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMembersyk:SpinalImplantsMember2025-01-012025-03-310000310764us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMembersyk:SpinalImplantsMember2025-12-310000310764us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMembersyk:SpinalImplantsMember2025-04-300000310764us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMembersyk:SpinalImplantsMember2024-12-31

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

~~WASHINGTON~~Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of ~~the~~Report ~~Securities~~(Date ~~Exchange~~of ~~Act~~earliest ofevent ~~1934~~reported): June 26, 2026

~~Date~~STRYKER ~~of Report (Date of earliest event reported): May 15, 2026~~CORPORATION

(Exact ~~Stryker~~name ~~Corporation~~of registrant as specified in its charter)

(Exact name of Registrant as Specified in Its Charter)

Michigan

001-13149

38-1239739

(State of incorporation)

(Commission File Number)

(I.R.S. Employer Identification No.)

1941 Stryker Way

Portage,

Michigan

49002

(Address of principal executive offices)

(Zip Code)

(269)

385-2600

(Registrant’s telephone number, including area code)

Michigan		001-13149		38-1239739
(State or Other Jurisdictionof Incorporation)		(Commission File Number)		(IRS EmployerIdentification No.)

1941 Stryker Way
Portage, Michigan		49002
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s Telephone Number, Including Area Code: (269) 385-2600

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

~~TradingSymbol(s)~~

~~Name of each exchange on which registered~~

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $.10 Par Value

~~SYK~~

~~New York Stock Exchange~~

SYK

New York Stock Exchange

2.125% Notes due 2027

~~SYK27~~

~~New York Stock Exchange~~

SYK27

New York Stock Exchange

3.375% Notes due 2028

~~SYK28~~

~~New York Stock Exchange~~

SYK28

New York Stock Exchange

0.750% Notes due 2029

~~SYK29~~

~~New York Stock Exchange~~

SYK29

New York Stock Exchange

2.625% Notes due 2030

~~SYK30~~

~~New York Stock Exchange~~

SYK30

New York Stock Exchange

1.000% Notes due 2031

~~SYK31~~

~~New York Stock Exchange~~

SYK31

New York Stock Exchange

3.375% Notes due 2032

~~SYK32~~

~~New York Stock Exchange~~

SYK32

New York Stock Exchange

3.625% Notes due 2036

~~SYK36~~

~~New York Stock Exchange~~

SYK36

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging ~~growth~~Growth ~~company~~Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

~~Item~~ITEM 58.0201 ~~Departure~~OTHER ~~of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.~~EVENTS

~~Stryker~~Segment ~~Corporation~~Reporting (the “Company”) announced on May 20, 2026 that William E. Berry, Jr. has decided to retire from his role as Vice President, Chief Accounting Officer of the Company effective September 1, 2026 and that Emily Baculik, who currently serves as Vice President, Corporate Controller, will also serve as chief accounting officer of the Company effective September 1, 2026. Changes

~~There~~In ~~are~~the nofirst ~~arrangements~~quarter or2026 ~~understandings~~Stryker ~~between~~Corporation ~~Ms. Baculik~~("we" ~~and~~or ~~any~~the ~~person~~"Company") ~~pursuant~~announced toa ~~which~~change Msin our organizational structure. ~~Baculik~~ ~~was~~Our ~~selected~~new asOrtho anTech ~~officer,~~business ~~and~~combines nothe ~~family~~orthopaedic ~~relationships~~instruments ~~exist~~portfolio ~~between~~from ~~Ms. Baculik~~our Instruments business with the Mako and ~~any~~enabling ~~director~~technologies orportfolio ~~executive~~from ~~officer~~our ofOther ~~the~~Orthopaedics ~~Company~~business. ~~Ms. Baculik~~By isbringing ~~not~~Mako, apower ~~party~~tools, tocutting ~~any~~accessories, ~~transaction~~enabling totechnologies ~~which~~and the ~~Company~~teams isbehind orthese ~~was~~products atogether ~~participant~~under ~~and~~one inbusiness, ~~which~~we ~~Ms. Baculik~~are ~~has~~simplifying athe ~~direct~~customer orexperience ~~indirect~~and ~~material~~striving ~~interest subject~~ to ~~disclosure~~increase ~~under~~our ~~Item~~speed ~~404(a)~~to ofmarket ~~Regulation~~through ~~S-K~~focused innovation.

~~Biographical~~Following ~~Information~~this reorganization we will continue to have two business segments - (i) MedSurg and Neurotechnology and (ii) Orthopaedics, each of which comprise a reportable segment.

~~Ms. Baculik~~The rules of the Securities and Exchange Commission require that when a registrant prepares, ~~age~~on 46or after the date a registrant reports an accounting change such as the segment changes noted above, ~~has~~a ~~been~~new ~~Vice~~registration, ~~President~~proxy, ~~Corporate~~or ~~Controller~~information atstatement ~~the~~(or ~~Company~~amends ~~since~~a ~~November~~previously ~~2024.~~filed ~~Prior~~registration, toproxy, or information statement) that, ~~she~~includes ~~was~~or ~~Vice~~incorporates ~~President~~by reference financial statements, ~~Finance~~the ~~for~~registrant must recast the ~~Spine~~prior ~~Division~~period ~~from~~financial ~~September~~statements ~~2022~~included toor ~~November~~incorporated ~~2024~~by ~~and~~reference ~~Senior~~in ~~Director~~the registration, ~~Finance~~proxy, ~~from~~or ~~June~~information ~~2021~~statement to ~~September~~reflect ~~2022.~~these Mstypes of changes. ~~Baculik~~ ~~has~~Accordingly, ~~more~~the ~~than~~Company 20is ~~years~~filing ofthis ~~finance~~Form ~~and~~8-K ~~accounting~~to ~~experience~~recast ~~with~~our ~~publicly~~consolidated ~~traded~~financial ~~companies~~statements ~~and~~for ~~has~~each ~~prior~~of ~~experience~~the three years in ~~external~~the ~~financial~~period ~~reporting,~~ended ~~technical~~December ~~accounting~~31, ~~compliance~~2025, ~~and~~to ~~controllership~~reflect atthe ~~Eaton,~~changes ~~Rockwell~~in ~~Collins,~~segment ~~Ingersoll~~reporting ~~Rand~~as ~~and~~described Uabove.S. ~~Steel.~~The ~~Ms. Baculik~~updates ~~graduated~~do ~~from~~not ~~the~~represent ~~University~~a restatement of ~~Notre~~previously ~~Dame~~issued ~~with~~financial astatements. ~~bachelor’s~~The ~~degree~~recast information of Items contained in ~~history~~the ~~and~~2025 ~~earned~~Form a10-K ~~master’s~~(the ~~degree~~"2025 Annual Report") is presented in ~~accounting~~Exhibit ~~from~~99.1 ~~The~~to ~~Ohio~~this ~~State~~Form ~~University~~8-K, which is incorporated herein by reference.

~~Transition~~The ~~Agreement~~information included in this Form 8-K is presented for informational purposes only in connection with Mrthe segment reporting changes described above and does not amend or restate our audited consolidated financial statements, which were included in the 2025 Annual Report. ~~Berry~~This filing does not reflect any subsequent information or events occurring after we filed the 2025 Annual Report other than adjustments to reflect the updated segment information in conjunction with the change in business structure previously described. The recast included in Exhibit 99.1 to this Form 8-K reflects changes to the 2025 Annual Report as a result of the change in business structure. Without limitation of the foregoing, this filing does not purport to update Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in the 2025 Annual Report for any information, uncertainties, transactions, risks, events or trends occurring, or known to management. More current information is contained in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2026 (the “Quarterly Report on Form 10-Q”) and other filings with the Securities and Exchange Commission. This Form 8-K should be read in conjunction with the 2025 Annual Report and the Quarterly Report on Form 10-Q and other filings filed by us with the Securities and Exchange Commission. The Quarterly Report on Form 10-Q and other filings contain important information regarding events, developments and updates to certain expectations of the Company that have occurred since the filing of the 2025 Annual Report.

~~Mr. Berry~~ITEM has entered into a Transition Agreement with the Company pursuant to which he will continue to be employed as Advisor to the Chief Financial Officer from September 1, 2026 until August 15, 2027 (the “Advisory Period”)9.01 ~~During~~FINANCIAL ~~the~~STATEMENTS ~~Advisory~~AND Period, Mr. Berry will continue to receive base salary at his current annual rate of $510,000, and he will continue to be eligible to receive a 2026 incentive bonus with a target bonus percentage of 50% of his annual salary subject to the terms of the applicable bonus plan. Mr. Berry will not be eligible for an annual incentive bonus or any prorated bonus for services provided during 2027. Mr. Berry’s outstanding equity awards will be governed under the existing terms and conditions of the underlying award agreements and applicable long-term incentive plan, and he will not be eligible to receive any new equity awards during the term of his Advisory Period. EXHIBITS

Letter Agreement with Ms. Baculik


(d)	Exhibits
	23.1	Consent of Independent Registered Public Accounting Firm
	99.1	Recast of certain Items for Stryker's Annual Report on Form 10-K for the year ended December 31, 2025.
	101.INS	iXBRL Instance Document
	101.SCH	iXBRL Schema Document
	101.CAL	iXBRL Calculation Linkbase Document
	101.DEF	iXBRL Definition Linkbase Document
	101.LAB	iXBRL Label Linkbase Document
	104	Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)

Pursuant to the letter agreement establishing Ms. Baculik’s compensation, Ms. Baculik’s annualized base salary rate will increase to $420,000 effective September 1, 2026. Ms. Baculik’s bonus target will be 45% of her annual base salary, prorated for 2026 based on the portion of the year that she serves as the chief accounting officer of the Company and determined based on the applicable plan terms. In addition, a recommendation will be made to the Compensation and Human Capital Committee of the Board of Directors of the Company to approve awards to Ms. Baculik under the Company’s long-term incentive plan in February 2027. The awards would have an aggregate target value equal to approximately $400,000, comprised of 50% stock options (vesting 20% on each of the first five anniversary dates of the grant date) and 50% restricted stock units (vesting in three equal installments over an approximate three-year period after the grant date). SIGNATURES

The summary descriptions of the Transition Agreement with Mr. Berry and the letter agreement with Ms. Baculik contained in this Current Report on Form 8-K do not purport to be complete and are qualified in their entirety by, and should be read in conjunction with, the complete text of such agreements that are filed as Exhibit 10.1 and 10.2, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

10.1		Transition Agreement, dated May 15, 2026, between Stryker Corporation and William E. Berry, Jr..
10.2		Letter Agreement, dated May 15, 2026, between Stryker Corporation and Emily Baculik.
104		The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		~~STRYKER CORPORATION~~		STRYKER CORPORATION
		~~(Registrant)~~		(Registrant)
Dated: May 20, 2026		By:	/s/ Tina S. French
Date:	June 26, 2026			/s/ PRESTON W. WELLS
		Name:	Tina S. French
				Preston W. Wells
		Title:	Corporate Secretary
				Vice President, Chief Financial Officer

Filing Compare · STRYKER CORP